Cargando…
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
Autores principales: | Wan, Xueting, Song, Mengyao, Wang, Aiyun, Zhao, Yang, Wei, Zhonghong, Lu, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070099/ https://www.ncbi.nlm.nih.gov/pubmed/35529843 http://dx.doi.org/10.3389/fimmu.2022.887775 |
Ejemplares similares
-
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021) -
Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
por: Zheng, Weiwei, et al.
Publicado: (2022) -
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
por: Tu, Jingyao, et al.
Publicado: (2023) -
Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023) -
Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
por: Wan, Qi, et al.
Publicado: (2022)